Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Opko Health Inc (OPK)

Opko Health Inc (OPK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,071,498
  • Shares Outstanding, K 682,483
  • Annual Sales, $ 863,500 K
  • Annual Income, $ -188,860 K
  • EBIT $ -104 M
  • EBITDA $ 2 M
  • 60-Month Beta 1.62
  • Price/Sales 1.23
  • Price/Cash Flow N/A
  • Price/Book 0.78

Options Overview Details

View History
  • Implied Volatility 70.72% ( -9.50%)
  • Historical Volatility 32.56%
  • IV Percentile 42%
  • IV Rank 18.32%
  • IV High 339.52% on 12/27/23
  • IV Low 10.42% on 06/17/24
  • Put/Call Vol Ratio 0.03
  • Today's Volume 8,250
  • Volume Avg (30-Day) 2,705
  • Put/Call OI Ratio 0.48
  • Today's Open Interest 499,280
  • Open Int (30-Day) 491,521

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.09
  • Number of Estimates 5
  • High Estimate -0.03
  • Low Estimate -0.15
  • Prior Year -0.09
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4800 +4.05%
on 11/26/24
1.7600 -12.50%
on 12/12/24
-0.0400 (-2.53%)
since 11/20/24
3-Month
1.3700 +12.41%
on 11/07/24
1.7600 -12.50%
on 12/12/24
+0.0600 (+4.05%)
since 09/20/24
52-Week
0.8516 +80.84%
on 01/05/24
1.7600 -12.50%
on 12/12/24
-0.0200 (-1.28%)
since 12/20/23

Most Recent Stories

More News
Insider Purchase: CEO & Chairman of $OPK (OPK) Buys 500,000 Shares

PHILLIP MD ET AL FROST, the CEO & Chairman of $OPK ($OPK), bought 500,000 shares of the company on 12-11-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

OPK : 1.5400 (-1.91%)
Insider Purchase: CEO & Chairman of $OPK (OPK) Buys 199,072 Shares

PHILLIP MD ET AL FROST, the CEO & Chairman of $OPK ($OPK), bought 199,072 shares of the company on 11-29-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

OPK : 1.5400 (-1.91%)
OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference

OPK : 1.5400 (-1.91%)
Opko Health (OPK) Q3 2024 Earnings Call Transcript

OPK earnings call for the period ending September 30, 2024.

OPK : 1.5400 (-1.91%)
OPKO Health: Q3 Earnings Snapshot

OPKO Health: Q3 Earnings Snapshot

OPK : 1.5400 (-1.91%)
OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results

OPK : 1.5400 (-1.91%)
OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024

OPK : 1.5400 (-1.91%)
ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

OPK : 1.5400 (-1.91%)
Opko Health (OPK) Q2 2024 Earnings Call Transcript

OPK earnings call for the period ending June 30, 2024.

OPK : 1.5400 (-1.91%)
OPKO Health: Q2 Earnings Snapshot

OPKO Health: Q2 Earnings Snapshot

OPK : 1.5400 (-1.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and...

See More

Key Turning Points

3rd Resistance Point 1.6033
2nd Resistance Point 1.5867
1st Resistance Point 1.5633
Last Price 1.5400
1st Support Level 1.5233
2nd Support Level 1.5067
3rd Support Level 1.4833

See More

52-Week High 1.7600
Last Price 1.5400
Fibonacci 61.8% 1.4130
Fibonacci 50% 1.3058
Fibonacci 38.2% 1.1986
52-Week Low 0.8516

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar